Two-day Indo-US Health Dialogue begins on Monday

The 4th Indo-US Health Dialogue started on September 27, 2021. The Union Minister of State for Health, Bharati Pravin Pawar was India's spokesperson at the event whereas Loyce Pace led the US delegation.

The issues planned for deliberations encompass the areas of epidemiological research and surveillance, vaccine development, health system and policies, issues relating to zoonotic and water-borne diseases.

The issues planned for deliberations encompasses the areas of epidemiological research and surveillance, vaccine development, health system and policies, issues relating to zoonotic and water-borne diseases.

While inaugurating the two-day session, the Union Minister of State for Health, Bharati Pravin Pawar said, "A collaboration between India and the United States will advance scientific discovery and management of global health threats".

The minister also took up the issue of the mutual solidarity between the two counties during the Covid-19 pandemic. Pawar took the chance to express the enhanced collaboration between the two countries for each other's development with respect to pharmaceuticals, therapeutics and vaccine development.

He emphasized that both countries need to focus on the emerging areas to prevent and control infectious diseases by relying on a well-designed and scientific approach. She also said that for the overall development of the two countries, it is very necessary for both the countries to work together in creating the best health infrastructure in the world.

An MoU between the Ministry of Health and the US Department of Health and Human Services in the health sector has been finalized, which mainly covers issues relating to health safety and security, communicable diseases, non-communicable diseases and communicable diseases.